{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:19:04Z","timestamp":1760300344551,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12928-020-00641-x","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T15:02:32Z","timestamp":1579014152000},"page":"371-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-9620","authenticated-orcid":false,"given":"Masafumi","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"641_CR1","doi-asserted-by":"crossref","unstructured":"Marie PY, Danchin N, Durand JF, Feldmann L, Grentzinger A, Olivier P, et al. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. J Am Coll Cardiol 1995;26: 879\u2013886.","DOI":"10.1016\/0735-1097(95)00243-9"},{"key":"641_CR2","doi-asserted-by":"crossref","unstructured":"Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49: 2105\u20132111.","DOI":"10.1016\/j.jacc.2007.01.087"},{"key":"641_CR3","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"M Task Force","year":"2013","unstructured":"Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949\u20133003.","journal-title":"Eur Heart J"},{"key":"641_CR4","doi-asserted-by":"crossref","unstructured":"Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360: 213\u2013224.","DOI":"10.1056\/NEJMoa0807611"},{"key":"641_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jcin.2015.01.039","volume":"8","author":"NP Johnson","year":"2015","unstructured":"Johnson NP, Johnson DT, Kirkeeide RL, Berry C, De Bruyne B, Fearon WF, et al. Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC Cardiovasc Interv. 2015;8:1018\u201327.","journal-title":"JACC Cardiovasc Interv"},{"key":"641_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jjcc.2015.12.005","volume":"68","author":"T Nishi","year":"2016","unstructured":"Nishi T, Kitahara H, Iwata Y, Fujimoto Y, Nakayama T, Takahara M, et al. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve. J Cardiol. 2016;68:512\u20136.","journal-title":"J Cardiol"},{"key":"641_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12928-017-0456-y","volume":"33","author":"M Nakayama","year":"2018","unstructured":"Nakayama M, Chikamori T, Uchiyama T, Kimura Y, Hijikata N, Ito R, et al. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate. Cardiovasc Interv Ther. 2018;33:116\u201324.","journal-title":"Cardiovasc Interv Ther"},{"key":"641_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1253\/circj.CJ-14-1118","volume":"79","author":"M Nakayama","year":"2015","unstructured":"Nakayama M, Tanaka N, Sakoda K, Hokama Y, Hoshino K, Kimura Y, et al. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease. Circ J. 2015;79:530\u20136.","journal-title":"Circ J"},{"key":"641_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2169\/internalmedicine.51.6567","volume":"51","author":"M Nakayama","year":"2012","unstructured":"Nakayama M, Saito A, Kitazawa H, Takahashi M, Sato M, Fuse K, et al. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T\u2013U waves in four cases. Intern Med. 2012;51:351\u20136.","journal-title":"Intern Med"},{"key":"641_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1253\/circj.CJ-13-0161","volume":"77","author":"NH Pijls","year":"2013","unstructured":"Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561\u20139.","journal-title":"Circ J"},{"issue":"Suppl 1","key":"641_CR11","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.2337\/dc12-s064","volume":"35","author":"DA American","year":"2012","unstructured":"American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64\u201371.","journal-title":"Diabetes Care"},{"key":"641_CR12","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159\u2013219.","journal-title":"Eur Heart J"},{"key":"641_CR13","doi-asserted-by":"crossref","unstructured":"Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. J Atheroscler Thromb 2013;20: 733\u2013742.","DOI":"10.5551\/jat.17368"},{"key":"641_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jacc.2011.09.077","volume":"59","author":"NH Pijls","year":"2012","unstructured":"Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol. 2012;59:1045\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"641_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ccd.25752","volume":"85","author":"WH Lim","year":"2015","unstructured":"Lim WH, Koo BK, Nam CW, Doh JH, Park JJ, Yang HM, et al. Variability of fractional flow reserve according to the methods of hyperemia induction. Catheter Cardiovasc Interv. 2015;85:970\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"key":"641_CR16","first-page":"248","volume":"8","author":"X Zhang","year":"1993","unstructured":"Zhang X, Shen W, Cai X, Zheng A. Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases. Chin Med Sci J. 1993;8:248\u20139.","journal-title":"Chin Med Sci J"},{"key":"641_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0735-1097(10)80048-8","volume":"15","author":"CL Talman","year":"1990","unstructured":"Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML. Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine. J Am Coll Cardiol. 1990;15:275\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"641_CR18","doi-asserted-by":"crossref","unstructured":"Vrolix M, Piessens J, Geest HD. Torsades de pointes after intracoronary papaverine. Eur Heart J 1991; 12: 273\u2013276.","DOI":"10.1093\/oxfordjournals.eurheartj.a059880"},{"key":"641_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000176323","volume":"84","author":"T Inoue","year":"1994","unstructured":"Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y. QT Prolongation and possibility of ventricular arrhythmias after intracoronary papaverine. Cardiology. 1994;84:9\u201313.","journal-title":"Cardiology"},{"key":"641_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ccd.1810180413","volume":"18","author":"A Jain","year":"1989","unstructured":"Jain A, Jenkins MG. Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine. Cathet Cardiovasc Diagn. 1989;18:255\u20137.","journal-title":"Cathet Cardiovasc Diagn"},{"key":"641_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/0002-9149(88)90281-0","volume":"62","author":"RF Wilson","year":"1988","unstructured":"Wilson RF, White CW. Serious ventricular dysrhythmias after intracoronary papaverine. Am J Cardiol. 1988;62:1301\u20132.","journal-title":"Am J Cardiol"},{"key":"641_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ccd.1810190402","volume":"19","author":"MJ Kern","year":"1990","unstructured":"Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T. Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve. Cathet Cardiovasc Diagn. 1990;19:229\u201336.","journal-title":"Cathet Cardiovasc Diagn"},{"key":"641_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jacc.2009.03.043","volume":"54","author":"P Kirchhof","year":"2009","unstructured":"Kirchhof P, Franz MR, Bardai A, Wilde AM. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. J Am Coll Cardiol. 2009;54:143\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"641_CR24","doi-asserted-by":"crossref","unstructured":"Habbab MdA, El-Sherie N. Drug-induced torsades de pointes: role of early afterdepolarizations and dispersion of repolarization. Am J Med 1990;89: 241\u2013246.","DOI":"10.1016\/0002-9343(90)90307-Y"},{"key":"641_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1540-8167.1994.tb01183.x","volume":"5","author":"W Shimizu","year":"1994","unstructured":"Shimizu W, Ohe T, Kurita T, Tokuda T, Shimomura K. Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1994;5:438\u201344.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"641_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0033-0620(88)90014-X","volume":"31","author":"WM Jackman","year":"1988","unstructured":"Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988;31:115\u201372.","journal-title":"Prog Cardiovasc Dis"},{"key":"641_CR27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","volume":"29","author":"KE Trinkley","year":"2013","unstructured":"Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin. 2013;29:1719\u201326.","journal-title":"Curr Med Res Opin"},{"key":"641_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/1096-8628(20010201)98:4<348::AID-AJMG1109>3.0.CO;2-A","volume":"98","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Horie M, Otani H, Kawashima T, Onishi Y, Sasayama S. Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2\u2013S3 inner loop of HERG. Am J Med Genet. 2001;98:348\u201352.","journal-title":"Am J Med Genet"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-020-00641-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T22:58:50Z","timestamp":1610578730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-020-00641-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1007\/s12928-020-00641-x","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"type":"print","value":"1868-4300"},{"type":"electronic","value":"1868-4297"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T.N. serves as a consultant for St. Jude Medical, Philips Volcano Japan, and Boston Scientific. The other authors report no relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}